Oura filed for an initial public offering on Thursday, and the numbers inside tell a story that stops you mid-scroll. The smart ring company generated $1.21 billion in sales for the nine-month period through June. Revenue grew 74 percent year-over-year during that stretch. Net losses increased to $924.3 million from $182.8 million in the same period a year earlier.

The company reports about 5 million paying members, with 72 percent women. Oura is aiming to raise as much as $3 billion through its IPO. The shares will trade on Nasdaq under the ticker OURA.

Growth That Costs More Every Year

Here is the thing about those loss numbers. The filing shows the losses include the effect of a deemed dividend paid to certain holders of redeemable convertible preferred stock. That is accounting language for money moving to early investors before the public gets a shot. It does not mean the company burned $924.3 million in cash operations. But it does mean common stockholders saw that loss hit their slice of the pie.

For the full year ending in June, Oura pulled in about $1.4 billion in revenue and reported $59 million in net income. That annual picture looks different from the nine-month loss number. Investors will have to decide which frame matters more when they price the stock.

The company filed confidentially in May. Now the registration statement is public, and the underwriters are lined up. Goldman Sachs, Morgan Stanley, J.P. Morgan, Allen & Company, and Jefferies will lead the offering. BofA Securities, Barclays, and Wells Fargo Securities will also run books on the deal. A long list of other firms will help sell shares to institutions and retail investors.

The Quiet Math Behind the Ring

You can feel the tension in these numbers. Revenue up 74 percent. Losses up by a lot more. That is the pattern of a company racing to grab market share before someone else does. Oura makes a small metal band that tracks sleep, heart rate, and recovery metrics. People wear it instead of a watch. The device has no screen. It just sits there and measures.

The bet is simple. Get millions of people hooked on their health data. Keep them paying a monthly subscription. Expand into clinical partnerships and employer health plans. Turn a wearable into a platform. That story has worked before in tech. It has also ended badly for investors who bought at the top.

Oura now has 5 million paying members. That base doubled in the last year. Seventy-two percent are women. The company says it can support much larger populations as it expands access and builds clinical evidence. It wants deeper integrations with health plans, employers, and care providers. That is the growth pitch.

The valuation target sits above $16 billion. Bloomberg reported that number in August, and the filing does not contradict it. A $3 billion raise would value Oura nearly 50 percent higher than the $11 billion mark from its 2025 funding round. That round raised more than $900 million. Existing investors are expected to sell shares in this IPO too. Oura will not receive proceeds from those secondary sales.

There is another detail worth holding. Oura was founded in Finland. It is now incorporated in the United States with its base in San Francisco. The company taps Netflix, Robinhood, and Deliveroo veterans for its board ahead of this listing. Those are people who know how to scale consumer businesses in public markets. They also know what happens when growth slows and losses persist.

The pricing and share count remain unset. The deal could close as soon as this month. Renaissance Capital estimates the offering could exceed $2.5 billion, but that is an outside guess. The final size depends on demand from funds and retail buyers when the roadshow hits.

What happens next is the part where you and I both go quiet. Investors will watch if Oura can turn growth into profit as it seeks this funding. The annual filing shows a path to profitability with that $59 million net income on $1.4 billion in revenue. The nine-month filing shows losses widening faster than sales. Both are true. Both matter.

The ring itself does not care. It just measures. The market will decide if the story behind the data is worth $16 billion or something less. Oura filed the paperwork. The numbers are on the table. Now the public gets to vote with real money.

More on: Investing